Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. Proficiency in spoken and written English Demonstrated expertise in one or more of the following areas: genome integrity, stem cell culture, quantitative and live-cell microscopy, or bioinformatics We offer Two
-
BBSRC Yorkshire Bioscience DLA Programme: Human Stem Cell-Based Approaches for Neurotoxicity Testing of Environmental Contaminants (CASE Project) School of Biosciences PhD Research Project
-
-funded research projects, this position provides support in the operation of the research laboratory. The responsibilities will include preparation of human stem cell cultures from repository specimens
-
We are seeking an enthusiastic and highly motivated Postdoctoral Research Associate to join the Birket Lab, an ambitious team pioneering research in human pluripotent stem cell (hPSC) biology and
-
will be determined by the supervisor. What you'll do Cell culture and maintenance of pluripotent stem cells and differentiating inner ear and skin organoids under sterile conditions Immunohistochemistry
-
Range: The per credit rate is $2,208 - $2,885 To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Part-Time-Lecturer--Stem-Cells---Regeneration--CGT-program
-
- and stem cell biology, and great synergy with renowned research groups. More information on the IMMENS and open positions available at the Åbo Akademi University in Turku can be found here: https
-
state-of-the-art facilities, cutting-edge expertise in vascular-, tumor-, immunological- and stem cell biology, and great synergy with renowned research groups. More information on the IMMENS and open
-
Post-doctoral Fellow in the Department of Orthopaedics and Traumatology, School of Clinical Medicine
) to model orthopedic pathologies. Manage and perform functional studies using animal models (e.g., transgenic mice) to evaluate disease progression and therapeutic efficacy. Utilize induced pluripotent stem
-
or induced pluripotent stem cells (iPSCs) derived from patient peripheral blood mononuclear cells. Validation will include stimulating or inhibiting target pathways using antagonists or agonists, or using gene